QMH And HKU Investigate Doctor Over Painkillers

"); jQuery("#212 h3").html("

"); });
2022-10-27 HKT 00:27
Queen Mary Hospital on Wednesday said an investigation is underway, after it received a report that a doctor was suspected of improperly obtaining morphine oral analgesics, or painkillers.
In a statement, the Hospital Authority said the doctor concerned works at the Li Ka Shing Faculty of Medicine at the University of Hong Kong, and that Queen Mary Hospital and the university had set up a joint committee to look into the matter.
It said last Saturday, this committee had met with the doctor to see whether any criminal element was involved, and that police had been informed. It also said several other doctors appeared to have prescribed the drugs between February and August.
The authority said the doctor was now on leave and that Queen Mary Hospital had reviewed patient records, and no patient had been affected.
Queen Mary Hospital in Pokfulam is the teaching hospital for the Li Ka Shing Faculty of Medicine.
Adyen And JCB Launch Card-on-File Tokenisation To Boost Payment Security
Adyen and JCB Co., Ltd. have launched JCB’s card-on-file (COF) tokenisation service, designed to improve the securit... Read more
Hong Kongs Cashless Future Is Closer Than You Think
A recent Worldpay report indicated that the digital wallets Hong Kong has could dominate its payment landscape by 2030.... Read more
HKMA Green Fintech Competition Open For Submissions
The Hong Kong Monetary Authority (HKMA) announced the launch of the 2025 Green Fintech Competition on 9 May 2025. It is... Read more
HSBC Launches Refreshed Hong Kong App With Smarter, Personalised Features
HSBC Hong Kong announced the launch of it refreshed HSBC HK App on 7 May 2025, set to roll out by phases beginning mid-... Read more
Chubb Life Hong Kong Launches Health Up Insurance For The Tech-Savvy
Chubb Life Hong Kong introduced the Health Up Insurance Plan (Health Up) on 7 May 2025. The Chubb Health Up Insurance d... Read more
Ant International Eyes Hong Kong IPO, In Talks With Regulators
Ant Group, a subsidiary of China’s Alibaba Group, is reportedly planning to list its overseas branch, Ant Internation... Read more